TNF and lymphoma: Studies revealed that relative to patients who had not been exposed to anti-TNF-α, those receiving anti-TNF-α monotherapy had a pooled Incidence Rate Ratio (IRR) of lymphoma of 1.52 per 1000 patient-years (95% CI: 1.06–2.19; p = 0.023) [28].